Abstract
The critical bone defects (CBD) are tissue damage that exceeds the bone's regenerative capacity, leading to disabling structural and functional consequences for the musculoskeletal system. Conventional treatment techniques for CBD have limitations, mainly related to the reduced amount of autologous bone tissue available for grafting. Faced with this challenge, regenerative medicine (RM) i…